Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993, Administered Via the Multi-dose Reservoir NEXThaler Dry Powder Inhaler and Via a HFA-pressurised Metered Dose Inhaler With and Without Valved Holding Chamber, in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Beclometasone/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Chiesi Farmaceutici SpA
- 22 Aug 2016 Status changed from recruiting to completed.
- 20 Apr 2016 Status changed from not yet recruiting to recruiting.
- 20 Apr 2016 New trial record